Skip to main content

Advertisement

Figure 4 | BMC Cancer

Figure 4

From: A novel oxygen carrier “YQ23” suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells

Figure 4

YQ23 increased liver pO 2 during hepatic I/R procedure. Liver pO2 level was directly monitored by the OxyLab® in vivo monitoring system during the ischemia and reperfusion procedures. (A) Representative liver pO2 curves during ischemia reperfusion procedures were presented. (B) Average liver pO2 level was showed at different time points during ischemia reperfusion procedures. (*p < 0.05; Treatment group N = 6; Control group N = 7).

Back to article page